Atlas Venture Associates X, L.P. Kymera Therapeutics, Inc. (KYMR) insider trading activity

Atlas Venture Associates X, L.P. is > 10% Shareholder of Kymera Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KYMR, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2021, when has been sold 242,133 shares (Common Stock) at a price of $61.0 per share, resulting in proceeds of $14,770,113. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

ATLAS VENTURE ASSOCIATES X, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Aug 11 2021	SELL Open market or private sale	$14,770,113 $61.0 p/Share	242,133 Reduced 100.0%	0 Common Stock
Mar 12 2021	SELL Open market or private sale	$12,958,275 $56.5 p/Share	229,350 Reduced 100.0%	0 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

AVA